JPS5933222A - 合成デオキシリボ核酸を有効成分とする抗腫瘍剤 - Google Patents

合成デオキシリボ核酸を有効成分とする抗腫瘍剤

Info

Publication number
JPS5933222A
JPS5933222A JP14339882A JP14339882A JPS5933222A JP S5933222 A JPS5933222 A JP S5933222A JP 14339882 A JP14339882 A JP 14339882A JP 14339882 A JP14339882 A JP 14339882A JP S5933222 A JPS5933222 A JP S5933222A
Authority
JP
Japan
Prior art keywords
acid
active ingredient
poly
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14339882A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0534338B2 (en, 2012
Inventor
Shizuo Shimada
島田　静雄
Osamu Yano
矢野　理
Junichi Furukawa
純一 古川
Etsuro Kuramoto
蔵本　悦郎
Haruo Sato
春夫 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP14339882A priority Critical patent/JPS5933222A/ja
Publication of JPS5933222A publication Critical patent/JPS5933222A/ja
Publication of JPH0534338B2 publication Critical patent/JPH0534338B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP14339882A 1982-08-20 1982-08-20 合成デオキシリボ核酸を有効成分とする抗腫瘍剤 Granted JPS5933222A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14339882A JPS5933222A (ja) 1982-08-20 1982-08-20 合成デオキシリボ核酸を有効成分とする抗腫瘍剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14339882A JPS5933222A (ja) 1982-08-20 1982-08-20 合成デオキシリボ核酸を有効成分とする抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS5933222A true JPS5933222A (ja) 1984-02-23
JPH0534338B2 JPH0534338B2 (en, 2012) 1993-05-21

Family

ID=15337834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14339882A Granted JPS5933222A (ja) 1982-08-20 1982-08-20 合成デオキシリボ核酸を有効成分とする抗腫瘍剤

Country Status (1)

Country Link
JP (1) JPS5933222A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018987A1 (en) * 1993-02-19 1994-09-01 Nippon Shinyaku Co., Ltd. Drug composition containing nucleic acid copolymer

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590384B2 (en) 2014-01-14 2020-03-17 Luterion Co., Ltd. Luterial and method for isolating and culturing the same
CN106536748A (zh) 2014-01-14 2017-03-22 崔元哲 Luterial和用于其分离及培养的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57145815A (en) * 1981-03-04 1982-09-09 Sanraku Inc Antitumor agent
JPS5855499A (ja) * 1981-09-28 1983-04-01 Sanraku Inc 抗腫瘍性を有する変性デオキシリボ核酸の製法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57145815A (en) * 1981-03-04 1982-09-09 Sanraku Inc Antitumor agent
JPS5855499A (ja) * 1981-09-28 1983-04-01 Sanraku Inc 抗腫瘍性を有する変性デオキシリボ核酸の製法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018987A1 (en) * 1993-02-19 1994-09-01 Nippon Shinyaku Co., Ltd. Drug composition containing nucleic acid copolymer

Also Published As

Publication number Publication date
JPH0534338B2 (en, 2012) 1993-05-21

Similar Documents

Publication Publication Date Title
CN116808219A (zh) 用于治疗免疫系统功能障碍的γ分泌酶调节剂
JP2020055884A (ja) がんのためのグルフォスファミド組み合わせ療法
CN105705148A (zh) 使用普那布林和紫杉烷的组合的癌症疗法
US6063814A (en) Phorbol esters as anti-neoplastic and white blood cell elevating agents
WO2019206159A1 (zh) 绿原酸及其组合物在制备治疗肉瘤的药物中的用途
EP0350801A2 (en) Polyprenols and polyprenyl phosphates for the inhibition of tumour metastasis
JPS61151123A (ja) 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤
JPS6287516A (ja) 悪性腫瘍の生体外での処置法
JPS63145229A (ja) ビタミンｂ６含有医薬組成物
WO1998039013A1 (en) Composition and method for treating cancer and immunological disorders resulting in chronic conditions
US4384001A (en) Treatment of tumors with thiazolidine-4-carboxylic acid
Gottschalk et al. The action of cortisone and ACTH on transplanted mouse tumors
WO2005023273A1 (en) Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents
JPS5933222A (ja) 合成デオキシリボ核酸を有効成分とする抗腫瘍剤
CA3170021A1 (en) Use of pyrido[1,2-a]pyrimidinone compound in treating lymphoma
JPH07116031B2 (ja) 制癌剤
WO1992011247A1 (en) Anticancer composition and compound
CN107308121A (zh) 肝脏再生的治疗剂
CN110876803B (zh) 一种包含乳蛋白和油酸的药物组合物
JPH08165236A (ja) 下痢の予防及び治療剤
EP1210944A1 (en) Blood plasma replacement solution
CN109846876B (zh) 木脂素类化合物在抗肿瘤中的应用及其药物制备
Sung et al. Re-evaluation of 5-fluorouracil as a single agent for gestational malignant trophoblastic neoplasms
JPH0211513A (ja) 制癌剤
CA1319107C (en) Formulations for inhibiting glucose transport